Simplex Trading, LLC Adamis Pharmaceuticals Corp Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.1 - $0.3 $647 - $1,941	6,470 Added 263.01%	8,930 $1,000
Q4 2022 Feb 02, 2023	SELL	$0.14 - $0.22 $409 - $644	-2,928 Reduced 54.34%	2,460 $0
Q3 2022 Nov 04, 2022	BUY	$0.24 - $0.54 $1,293 - $2,909	5,388 New	5,388 $1,000
Q2 2021 Aug 12, 2021	SELL	$0.66 - $1.23 $7,879 - $14,683	-11,938 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$0.54 - $1.79 $6,446 - $21,369	11,938 New	11,938 $11,000
Q3 2019 Oct 15, 2019	SELL	$0.7 - $1.46 $567 - $1,184	-811 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$1.26 - $2.23 $1,021 - $1,808	811 New	811 $1,000
Q4 2018 Jan 16, 2019	SELL	$2.1 - $3.21 $62,655 - $95,773	-29,836 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$2.25 - $4.8 $67,131 - $143,212	29,836 New	29,836 $104,000
Q2 2018 Jul 30, 2018	SELL	$3.2 - $4.7 $107,737 - $158,239	-33,668 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$2.55 - $4.85 $84,081 - $159,919	32,973 Added 4744.32%	33,668 $117,000
Q4 2017 Jan 10, 2018	SELL	$3.5 - $5.65 $86,698 - $139,956	-24,771 Reduced 97.27%	695 $3,000
Q3 2017 Oct 25, 2017	BUY	$4.5 - $5.65 $114,597 - $143,882	25,466	25,466 $133,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.